Johnson & Johnson (NYSE: JNJ) announced today the U.S. Food and Drug Administration (FDA) approval of a supplemental New Drug Application (sNDA) for SPRAVATO® (esketamine) CIII nasal spray, making ...

Travelers’ reward points and miles worth less; government agency warns company against devaluations The cruise line is sure ...

Apart from being one of the biggest spiritual congregations, Maha Kumbh has been a trade hotspot for many centuries. What are ...

In today's dynamic market, a select group of companies is transforming challenges into opportunities and paving the way for ...

Charles River expands Apollo ecosystem, offering bespoke client experiences that enable data-driven decision making.